photo of

Details

Role Team Leader / Senior Research Fellow
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an...
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.

Top Publications

  • Walaza, S, Tempia, S, Dawood, H, Variava, E, Wolter, N, Dreyer, A, Moyes, J, Von Mollendorf, C, McMorrow, M, Von Gottberg, A, et al. The Impact of Influenza and Tuberculosis Interaction on Mortality Among Individuals Aged ≥15 Years Hospitalized With Severe Respiratory Illness in South Africa, 2010–2016. Open Forum Infectious Diseases 6(3) : ofz020 2019
    view publication
  • Wong, KK, Cohen, AL, Martinson, NA, Norris, SA, Tempia, S, von Mollendorf, C, Walaza, S, Madhi, SA, McMorrow, ML, Cohen, C. Responses to hypothetical health scenarios overestimate healthcare utilization for common infectious syndromes: a cross-sectional survey, South Africa, 2012. BMC Infectious Diseases 18(1) : 344 2018
    view publication
  • von Mollendorf, C, Hellferscee, O, Valley-Omar, Z, Treurnicht, FK, Walaza, S, Martinson, NA, Lebina, L, Mothlaoleng, K, Mahlase, G, Variava, E, et al. Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014.. The Journal of Infectious Diseases 218(8) : 1228 -1237 2018
    view publication
  • Chan, J, Nguyen, CD, Lai, JYR, Dunne, EM, Andrews, R, Blyth, CC, Datta, S, Fox, K, Ford, R, Hinds, J, et al. Determining the pneumococcal conjugate vaccine coverage required for indirect protection against vaccine-type pneumococcal carriage in low and middle-income countries: a protocol for a prospective observational study. BMJ Open 8(5) : e021512 2018
    view publication
  • Tempia, S, Walaza, S, Moyes, J, Cohen, AL, Mollendorf, C, McMorrow, ML, Mhlanga, S, Treurnicht, FK, Venter, M, Pretorius, M, et al. The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza‐associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013‐2015. Influenza and Other Respiratory Viruses 12(3) : 360 -373 2018
    view publication

Page 10 of 17